Taking Wegovy with ramipril: what your prescriber needs to know

You're on ramipril and wondering whether Wegovy is even on the table

It's a very reasonable thing to check. Ramipril is one of the most widely prescribed medicines in the UK (used for high blood pressure, heart failure and kidney protection in diabetes) so a lot of people starting to look into weight management will already have it in their medicine cabinet. The good news is that the British National Formulary does not list a direct interaction between semaglutide and ramipril, and clinical guidance does not flag the combination as contraindicated.

There is one common misconception worth clearing up here: some people assume that because ramipril is a blood-pressure medicine, adding any other treatment is off-limits without specialist sign-off from a cardiologist. That's not necessarily the case. Wegovy is assessed by a GPhC-registered prescriber who looks at your whole health profile (blood pressure history included) and makes an individual clinical decision. The combination is used in practice; what matters is that it's properly supervised.

You can read more about what semaglutide actually is and how it works on our semaglutide overview page, which covers the mechanism, the UK licence and the clinical evidence behind it.

Where the real caution lies: blood pressure and kidney function

Semaglutide has a modest blood-pressure-lowering effect in its own right, observed across the STEP programme trials. Add that to an ACE inhibitor like ramipril and blood pressure can fall further than either medicine would produce alone. For most people this is not a problem, and may actually be welcome if their pressure was running high. But if your blood pressure is already well-controlled and sitting at the lower end of target, your prescriber will want to know that, because dizziness or light-headedness on standing becomes more likely.

The bigger practical concern is kidney function. Ramipril is protective for the kidneys long-term, but ACE inhibitors reduce the kidney's ability to regulate blood flow when circulation drops. If Wegovy's GI side effects (nausea and vomiting are the most common in the early weeks) lead to poor fluid intake, that dehydration can put additional strain on the kidneys in people on ACE inhibitors. The NHS medicines guidance on semaglutide notes that severe vomiting or diarrhoea should prompt patients to stop their medicine temporarily and seek advice; with an ACE inhibitor in the mix, acting promptly matters more. You'll find useful background on drug interactions more broadly on our page covering what not to take with Wegovy.

This is not a reason to avoid Wegovy. It is a reason to stay well-hydrated, titrate slowly (which Wegovy's schedule already builds in), and tell your GP that you've started treatment, something our prescribers support as standard practice.

What the prescribing process looks at

At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, same working day. They will ask for your current medicines, including ramipril, and your most recent blood pressure readings. If you've had recent kidney function blood tests (a urea and electrolytes panel, often called U&Es), sharing those results is useful context, though not always required.

The prescriber may recommend that your GP is kept informed so your blood pressure can be monitored as you begin treatment, this is good clinical practice regardless of which pharmacy you use. Our pharmacy notifies your GP in line with GPhC guidance as part of the standard process.

It is also worth knowing that semaglutide interacts with oral contraceptives by slowing gastric emptying; ramipril does not share that mechanism, so there is no equivalent absorption concern. If you're also taking Alli alongside any of your current medicines, our page on whether you can take Alli with Wegovy covers that combination and what to be aware of. If you take other medicines alongside ramipril (statins are a common example) our page on Wegovy and statins covers that combination separately. The broader list of medicines that need careful prescriber assessment is covered on our full semaglutide interactions page.

Getting started if you're on ramipril

The practical path is straightforward. Fill in the free consultation at the nume treatment page, list ramipril under your current medicines, and give an honest account of your blood pressure history. The prescriber uses that information (not a checklist) to decide whether Wegovy is appropriate for you and at what starting dose.

If you're approved, treatment is dispatched the same day for orders placed before 12pm on a working day, arriving by tracked DPD delivery the next working day in plain packaging. Aftercare is available seven days a week if anything changes after you start.

One more practical note: Wegovy itself is a prescription-only medicine for weight management, licensed for adults with a BMI of 30 or above, or 27 or above with a weight-related condition such as high blood pressure, which ramipril use often signals. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Eligibility is never guaranteed by BMI alone, but the combination of a weight-related comorbidity and ramipril use often means the licence criteria are met. Our Wegovy treatment page has more on the evidence and what to expect across the first months of treatment. If you'd like a sense of what private weight management involves more broadly, the weight loss overview is a good starting point.